Regulatory

Illustration of the first-in-class ADHD drug Simtriyo

Regulatory

FDA Approves Simtriyo, a First-in-Class Non-Stimulant ADHD Drug

Otsuka's centanafadine is the first ADHD medicine to block reuptake of all three key neurotransmitters — a new mechanism for adults and children 6 and up.

1 hr ago · 1 min read

Illustration of a new FDA-approved blood test for colon cancer screening

Regulatory

FDA Approves a New Blood Test for Colorectal Cancer Screening

Freenome's SimpleScreen offers a needle-in-arm alternative to stool tests and colonoscopy — but its blind spot for precancerous growths means it's no replacement for a scope.

1 hr ago · 1 min read